Summary of Classification and Labelling
General Information
EC / List no.
|
Name |
CAS Number
|
|---|---|---|
| 620-314-7 | [(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate | 154229-18-2 |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| Acute Tox. 4 | H302 | H302 |
GHS07 GHS08 Wng |
 |
State/Form
|
19 | View details | ||||
| Repr. 2 | H361 (H361fd) | H361 | |||||||||
| Acute Tox. 4 | H302 | H302 |
GHS08 GHS07 Wng |
2 | View details | ||||||
| Repr. 2 | H361 (H361fd) | H361 | |||||||||
| Acute Tox. 4 | H302 | H302 |
GHS07 GHS08 Wng |
State/Form
|
1 | View details | |||||
| Skin Irrit. 2 | H315 | H315 | |||||||||
| Repr. 2 | H361 | H361 | |||||||||
| Acute Tox. 4 | H302 | H302 |
GHS08 GHS07 Wng |
1 | View details | ||||||
| Repr. 2 | H361 | H361 | |||||||||
| Not Classified | |
1 | |||||||||
| Repr. 2 | H361 (oral) (fd) | H361 (na) |
Wng |
State/Form
|
1 | View details | |||||
| H302 |
GHS07 Wng |
State/Form
|
1 | View details | |||||||
| Repr. 2 | H361 (fd) | H361 (Suspected of da...) |
GHS08 GHS09 Wng |
M(Chronic)=1000 |
State/Form
|
1 | View details | ||||
| STOT RE 2 | H373 (liver,adrenals,...) | H373 | |||||||||
| Aquatic Chronic 1 | H410 | H410 | |||||||||
| Repr. 1B | H360 (F) | H360 |
GHS08 GHS09 Dgr |
1 | View details | ||||||
| STOT RE 2 | H373 | H373 | |||||||||
| Aquatic Chronic 1 | H410 | H410 | |||||||||
| Not Classified | 1 | ||||||||||
| Repr. 1A | H360 (inhalation,oral) | H360 |
GHS08 Dgr |
State/Form
|
1 | View details | |||||
| STOT RE 1 | H372 (endocrine syste...) (inhalation,oral) | H372 | |||||||||
| Repr. 2 | H361 (H361d: Suspecte...) | H361 (Suspected of da...) |
GHS08 GHS09 Wng |
M(Chronic)=100 |
State/Form
|
1 | View details | ||||
| STOT RE 2 | H373 (Reproductive or...) | H373 (Reproductive or...) | |||||||||
| Aquatic Acute 1 | H400 | ||||||||||
| Aquatic Chronic 1 | H410 | H410 | |||||||||
| Acute Tox. 4 | H302 | H302 |
GHS07 GHS08 Wng |
1 | View details | ||||||
| Acute Tox. 4 | H332 | H332 | |||||||||
| STOT RE 2 | H373 (inhalation) | H373 | |||||||||
| Acute Tox. 4 | H302 | H302 |
GHS08 GHS07 GHS09 Dgr |
1 | View details | ||||||
| Repr. 1B | H360 (FD) | H360 | |||||||||
| STOT RE 2 | H373 (Liver) (oral) | H373 | |||||||||
| Aquatic Chronic 1 | H410 | H410 | |||||||||
| Repr. 1B | H360 (Fd) | H360 |
GHS08 GHS09 Dgr |
M(Chronic)=1000 M=1 |
1 | View details | |||||
| STOT RE 2 | H373 (testes) | H373 | |||||||||
| STOT RE 2 | H373 (adrenal glands) | H373 | |||||||||
| STOT RE 2 | H373 (liver) | H373 | |||||||||
| Aquatic Acute 1 | H400 | H400 | |||||||||
| Aquatic Chronic 1 | H410 | H410 | |||||||||
| Acute Tox. 4 | H302 | H302 |
GHS08 GHS07 GHS09 Dgr |
State/Form
|
1 | View details | |||||
| Repr. 1B | H360 | H360 | |||||||||
| STOT RE 2 | H373 (liver) | H373 (liver) | |||||||||
| Aquatic Acute 1 | H400 | H400 | |||||||||
| Aquatic Chronic 1 | H410 | H410 | |||||||||
| Repr. 1B | H360FD | H360FD |
GHS08 GHS09 Dgr |
M(Chronic)=1000 |
State/Form
|
1 | View details | ||||
| STOT RE 2 | H373 (liver) | H373 | |||||||||
| Aquatic Acute 1 | H400 | H400 | |||||||||
| Aquatic Chronic 1 | H410 | H410 | |||||||||
Number of Aggregated Notifications: 17